Search hospitals > New Jersey > New Brunswick
Rutgers University
Claim this profileNew Brunswick, New Jersey 08901
Conducts research for Coronavirus
Conducts research for Health Behaviors
Conducts research for Breast Cancer
Conducts research for Weight Loss
Conducts research for COVID-19
60 reported clinical trials
7 medical researchers
Summary
Rutgers University is a medical facility located in New Brunswick, New Jersey. This center is recognized for care of Coronavirus, Health Behaviors, Breast Cancer, Weight Loss, COVID-19 and other specialties. Rutgers University is involved with conducting 60 clinical trials across 135 conditions. There are 7 research doctors associated with this hospital, such as Gaurav Gupta, MD, Todd Rosen, MD, Gian Pal, and Emad Aziz, MD.Top PIs
Gaurav Gupta, MDVirginia Commonwealth University2 years of reported clinical research
Studies Kidney Complication
Studies Cytomegalovirus
6 reported clinical trials
9 drugs studied
Todd Rosen, MDRutgers Robert Wood Johnson University Hospital8 years of reported clinical research
Studies Pelvic Organ Prolapse
Studies Vaginal Birth
3 reported clinical trials
4 drugs studied
Gian PalRutgers Robert Wood Johnson Medical School2 years of reported clinical research
Studies Parkinson's Disease
Studies Neurodegenerative Diseases
3 reported clinical trials
4 drugs studied
Emad Aziz, MDRutgers Medical School5 years of reported clinical research
Studies Heart Failure
Studies Stroke
3 reported clinical trials
3 drugs studied
Clinical Trials running at Rutgers University
Breast Cancer
Coronavirus
Stroke
Multiple Sclerosis
Parkinson's Disease
Solid Tumors
Childhood Obesity
Gram-Negative Bacterial Infection
Depression
Autism Spectrum Disorder
RLY-2608 + Fulvestrant
for Breast Cancer
This is an open-label, FIH study designed to evaluate the maximum tolerated dose, recommended Phase 2 dose, safety, tolerability, PK, pharmacodynamics, and preliminary antineoplastic activity of RLY-2608, in advanced solid tumor patients with a Phosphatidylinositol-4,5-bisphosphate-3 kinase, catalytic subunit alpha (PIK3CA) mutation in blood and/or tumor per local assessment. The study will evaluate RLY-2608 as a single agent for patients with unresectable or metastatic solid tumors. It will also evaluate RLY-2608 in combination RLY-2608 + fulvestrant and in triple combination RLY-2608 + fulvestrant + CDK4/6 inhibitor (palbociclib or ribociclib) or CDK4 inhibitor (PF-07220060) for patients with HR+ HER2- locally advanced or metastatic breast cancer. The RLY-2608 single agent arm, RLY-2608 + fulvestrant combination arm, and triple combination arms will have 2 parts: a dose escalation (Part 1) and a dose expansion (Part 2).
Recruiting1 award Phase 113 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rutgers University?
Rutgers University is a medical facility located in New Brunswick, New Jersey. This center is recognized for care of Coronavirus, Health Behaviors, Breast Cancer, Weight Loss, COVID-19 and other specialties. Rutgers University is involved with conducting 60 clinical trials across 135 conditions. There are 7 research doctors associated with this hospital, such as Gaurav Gupta, MD, Todd Rosen, MD, Gian Pal, and Emad Aziz, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.